David Silverman of the School of Arts and Sciences and Penn Museum provides insight into ancient Egyptian lore, as Penn hosts the "Amarna: Ancient Egypt's Place in the Sun" exhibit.
Penn in the News
Lawrence Sherman of the School of Arts and Sciences is cited for research on using aggressive search tactics to combat concealed firearms.
Mauro Guillen of Penn’s Wharton School authors an op-ed on Spain’s rising stake in international business.
Max Kelz of the School of Medicine discusses the potential of a new anesthetic compound found in saliva.
Garret FitzGerald of the School of Medicine is cited for his research on the new painkiller Arcoxia.
Chris and Natasha Ashton of Penn's Wharton School are cited for founding pet insurance company, Fetch Inc. Jean Lemaire of Penn's Wharton School and Barry Stupine of the School of Veterinary Medicine discuss pet insurance.
Paul Sehnert of Facilities and Real Estate Services comments on Penn’s past redevelopment strategies.
Jonathan Moreno of the School of Medicine comments on the stem cell issue and its role in recent mid-term elections.
James Kirkpatrick of the School of Medicine says the vast majority of medical implants are discarded upon their owners’ deaths.
J. Russell Ramsay of the School of Medicine discusses adult ADHD.
Michael Useem of Penn’s Wharton School discusses corporate governance.
Paul Sehnert of Facility and Real Estate Services discusses Penn’s expansive building projects.
Andrew Newberg of the School of Medicine discusses the neuroscience of speaking in tongues.
Bruce Levine of the School of Medicine discusses a new gene therapy treatment for HIV.
Stephen Burbank of the Law School discusses judicial independence.
Georgette Chapman Phillips of Penn’s Wharton School says intangible development benefits are difficult to assess in court.
Dean Patrick Harker of Penn’s Wharton School is profiled.
Nathaniel Persily of the Law School comments on Republican strategy in the recent midterm elections.
Luzi Hail of Penn’s Wharton School is cited for a research publication, “International Differences in the Cost of Equity Capital: Do Legal Institutions and Securities Regulation Matter?”
Carl June and Bruce Levine of the School of Medicine are cited for their work on gene-therapy treatments that target HIV.